Keynote Speaker:
Scott Gottlieb, MD (view biography)
23rd Commissioner of the Food and Drug Administration (FDA)

The summit will explore the impact of new innovations and the rapidly shifting health policy landscape on access to high-quality cancer care in the United States. Experts in the field will identify strategies to ensure access and affordability to innovation and novel therapies, review current policies under the direction of Food and Drug Administration (FDA) Commissioner Scott Gottlieb to make oversight more effective and efficient, and discuss recent healthcare regulations and legislation and their real world implications for oncology stakeholders.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact Alyssa Schatz, Director, Policy and Advocacy, U.S. and Global Development. For any media questions, please contact Rachel Darwin, Public Relations Manager. 

Meeting Details

  • When

  • Monday, June 25, 2018
    8:30 AM - 3:15 PM
    Eastern Time

  • Where

  • The National Press Club
    529 14th Street NW
    13th Floor
    Washington, District of Columbia 20045

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!